Screener
Amgen AMGN Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Amgen in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.
The source filing: Amgen’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000318154-26-000126
FAQ
- What is Amgen's equity method investments?
- Amgen (AMGN) reported equity method investments of $301M in Q2 2026.
- What is the long-term trend for Amgen's equity method investments?
- Over 2 years (2020 to 2025), Amgen's equity method investments has grown at a 33.5% compound annual growth rate (CAGR), from $203M to $362M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.
Ask your AI about Amgen's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude